Artificial intelligence is advancing quicker in 2020 than it has in the past decade
Artificial intelligence (AI) has endless potential in every area of society, and recent advancements in healthcare are bound to revolutionize the modern healthcare industry. A recent study conducted at the UK’s University of Sheffield’s Neuroscience Institute investigated the use of AI to help relieve the time and financial impacts of the most common neurodegenerative diseases, such as Alzheimer’s and Parkinson’s. As a result, it was determined that AI can give a much faster diagnosis of Alzheimer’s and improve the prognosis.
Alzheimer’s disease is a neurological disorder that causes the death of brain cells, so patients suffer from great memory losses that end up developing into further cognitive declines. The main risks for this disease are found at advanced ages, and this is becoming a pressing matter as more populations around the world are living longer than ever before. According to the study, presumably, at least 115 million people will suffer this disease by 2050, which presents a challenge for healthcare systems.
In this study, the researchers noted how AI-derived technologies like machine learning algorithms can help professionals detect neurodegenerative disorders before they progress into worse symptoms. In this way, a patient has a chance to receive early treatment and perhaps delay the advancement of the disease. AI tools are being used to analyze which patients, who are currently showing mild cognitive impairment, will develop Alzheimer’s disease. It can also provide a source for patients to share their present symptoms from their own homes. These algorithms can then be trained to recognize any changes coming from medical images or patient movement information and help patients find treatment sooner, preventing the disease from taking over.
